Scopus BioPharma Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Scopus BioPharma Inc
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. The company product candidates would utilize synthetically-produced cannabinoids as opposed to plant-derived compounds. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.
/ 
Frequently asked questions
To buy Scopus BioPharma Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Scopus BioPharma Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Scopus BioPharma Inc is SCPS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Scopus BioPharma Inc has its primary listing on OTC Markets Group (Pink Sheets) – No Information. You can trade Scopus BioPharma Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Scopus BioPharma Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Scopus BioPharma Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Scopus BioPharma Inc.